- Home
- BRN vs IBIO Comparison
BRN vs IBIO Comparison
Compare BRN & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRN
- IBIO
- Stock Information
- Founded
- BRN 1956
- IBIO 2008
- Country
- BRN United States
- IBIO United States
- Employees
- BRN N/A
- IBIO N/A
- Industry
- BRN Oil & Gas Production
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- BRN Energy
- IBIO Health Care
- Exchange
- BRN Nasdaq
- IBIO Nasdaq
- Market Cap
- BRN 13.9M
- IBIO 15.9M
- IPO Year
- BRN N/A
- IBIO N/A
- Fundamental
- Price
- BRN $1.16
- IBIO $0.73
- Analyst Decision
- BRN
- IBIO Strong Buy
- Analyst Count
- BRN 0
- IBIO 3
- Target Price
- BRN N/A
- IBIO $4.87
- AVG Volume (30 Days)
- BRN 99.3K
- IBIO 5.5M
- Earning Date
- BRN 08-12-2025
- IBIO 05-02-2025
- Dividend Yield
- BRN N/A
- IBIO N/A
- EPS Growth
- BRN N/A
- IBIO N/A
- EPS
- BRN N/A
- IBIO N/A
- Revenue
- BRN $19,387,000.00
- IBIO $375,000.00
- Revenue This Year
- BRN N/A
- IBIO $36.00
- Revenue Next Year
- BRN N/A
- IBIO N/A
- P/E Ratio
- BRN N/A
- IBIO N/A
- Revenue Growth
- BRN N/A
- IBIO 650.00
- 52 Week Low
- BRN $1.08
- IBIO $0.64
- 52 Week High
- BRN $2.53
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- BRN 44.13
- IBIO 39.96
- Support Level
- BRN $1.11
- IBIO $0.71
- Resistance Level
- BRN $1.25
- IBIO $0.75
- Average True Range (ATR)
- BRN 0.07
- IBIO 0.05
- MACD
- BRN -0.00
- IBIO 0.00
- Stochastic Oscillator
- BRN 43.17
- IBIO 8.25
About BRN Barnwell Industries Inc.
Barnwell Industries Inc is an oil and gas firm. Its areas of operations include acquiring, developing, producing, and selling oil and natural gas. The company acquires and develops crude oil and natural gas assets. The company's operating segment includes Oil and natural gas, Contract drilling, Land investment, and Others. It generates maximum revenue from the Oil and natural gas segment. It operates in two geographical segments the United States, which generates a majority of revenue, and Canada.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.